Does intensive glucose control cancel out benefits of systolic blood pressure target <120 mmHg in patients with diabetes mellitus participating in accoRD?
(2018) In Hypertension 72(2). p.291-293
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/5ad446ca-ae5d-4186-9ff2-add40d08217d
- author
- Kjeldsen, Sverre E. ; Os, Ingrid and Nilsson, Peter M. LU
- organization
- publishing date
- 2018
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Hypertension
- volume
- 72
- issue
- 2
- pages
- 3 pages
- publisher
- Lippincott Williams & Wilkins
- external identifiers
-
- pmid:29967041
- scopus:85056421081
- ISSN
- 0194-911X
- DOI
- 10.1161/HYPERTENSIONAHA.118.11455
- language
- English
- LU publication?
- yes
- id
- 5ad446ca-ae5d-4186-9ff2-add40d08217d
- date added to LUP
- 2018-11-23 08:36:15
- date last changed
- 2024-01-30 03:22:59
@article{5ad446ca-ae5d-4186-9ff2-add40d08217d,
author = {{Kjeldsen, Sverre E. and Os, Ingrid and Nilsson, Peter M.}},
issn = {{0194-911X}},
language = {{eng}},
number = {{2}},
pages = {{291--293}},
publisher = {{Lippincott Williams & Wilkins}},
series = {{Hypertension}},
title = {{Does intensive glucose control cancel out benefits of systolic blood pressure target <120 mmHg in patients with diabetes mellitus participating in accoRD?}},
url = {{http://dx.doi.org/10.1161/HYPERTENSIONAHA.118.11455}},
doi = {{10.1161/HYPERTENSIONAHA.118.11455}},
volume = {{72}},
year = {{2018}},
}